Aberrant <scp>TIMP</scp>‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Paula Duch; Natalia Díaz‐Valdivia; Marta Gabasa; Rafael Ikemori; Marselina Arshakyan; Patricia Fernández‐Nogueira; Alejandro Llorente; Cristina Teixido; Josep Ramírez; Javier Pereda; Lourdes Chuliá‐Peris; José Marcelo Galbis; Frank Hilberg; Noemí Reguart; Derek C. Radisky; Jordi Alcaraz

Journal title: Cancer Science

Journal publisher: Oxford University Press

Published year: 2024

DOI identifier: 10.1111/cas.16141

ISSN: 1347-9032